We believe that The Chemours Company (NYSE:CC) is a solid choice for investors seeking exposure in the chemical space. Its solid product offerings, strengthening end markets and expansionary efforts bode well for the future.
The stock has been upgraded to a Zacks Rank #1 (Strong Buy) on Oct 3.
Why the Upgrade?
Sentiments are positive for Chemours Company, as evident from 38.1% rally in its share price over the last six months. The stock has outperformed 12.9% gain recorded by the industry it belongs to over the same period.
Also, earnings estimates for the stock have been revised upward by a couple of analysts in the last 60 days. The Zacks Consensus Estimate for 2017 improved 6.8% from $3.40 to $3.63 while that for 2018 increased 22.5% from $4.08 to $5.
Chemours Company (The) Price and Consensus
Air Products and Chemicals, Inc. (APD): Free Stock Analysis Report
FMC Corporation (FMC): Free Stock Analysis Report
Chemours Company (The) (CC): Free Stock Analysis Report
Innophos Holdings, Inc. (IPHS): Free Stock Analysis Report
Original post
Zacks Investment Research